1009-6213
2008 Issue 2
huan bao nie ji an mo fa yu fang gu ke da shou shu hou xia zhi shen jing mai xue shuan xing cheng de ti hui
yin yan lin ; yang xin ming ; zhang chun lin ; su feng
yin yan lin ; yang xin ming ; zhang chun lin ; su feng
..............page:95-96
A Case of Antiphospholipid Syndrome with Onset of Epilepsy
wang qing fang ; zhao kang ren ; qian jin jun ; xia hai ping ; zhao jing ; zhou hong
wang qing fang ; zhao kang ren ; qian jin jun ; xia hai ping ; zhao jing ; zhou hong
..............page:93-94
A Case of Antiphospholipid Syndrome with Nephropathy in SLE
zeng zhi yong ; chen jun min ; lin fang ; xue yuan ; zuo hong bing
zeng zhi yong ; chen jun min ; lin fang ; xue yuan ; zuo hong bing
..............page:91-93
Protocols of Initial Warfarin Treatment
LUO Wei-liang;ZHANG Shun-ling;XU Xian-ying
LUO Wei-liang;ZHANG Shun-ling;XU Xian-ying
..............page:88-90
Progress of Research with Antiphospholipid Syndrome
LI Tan;WU Jings-heng
LI Tan;WU Jings-heng
..............page:85-87
Malignant Tumor and Hemostatic Function
ZOU Li-fang;HU Jun-pei
ZOU Li-fang;HU Jun-pei
..............page:83-85
Advance in Protease-Activated Receptor 4
WANG Shun-lan;WANG Hai-yan;HE Shao-heng
WANG Shun-lan;WANG Hai-yan;HE Shao-heng
..............page:80-82
..............page:78-79
Early-stage Intra-Abdominal Hemorrhage in Patients Underwent Liver Transplantation and its Treatment.
LAI Tian-shun;GUO Zhen-hui;SUN Jie;TANG You-qing;HUO Feng;SU Lei
LAI Tian-shun;GUO Zhen-hui;SUN Jie;TANG You-qing;HUO Feng;SU Lei
..............page:74-77
Variations of Plasma Tissue Factor and Vascular Endothelial Growth Factor in Patients with Oral and Facial Tumors
DOU Hong-ju;ZOU Li-fang;Tang YONG;WANG Lei;Wang Xue-feng;HU Jun-pei
DOU Hong-ju;ZOU Li-fang;Tang YONG;WANG Lei;Wang Xue-feng;HU Jun-pei
..............page:71-73
Change of von Willebrand Factor in Patients with Coronary Heart Disease in Association with Heart Failure
ZHANG Wei;PAN Xue-yi;GUO Shu-zhu;XU Li-mei
ZHANG Wei;PAN Xue-yi;GUO Shu-zhu;XU Li-mei
..............page:69-70,73
Clinical Characteristics of Upper Extremity Deep Venous Thrombosis (A Report of 14 Cases)
ZHANG Zhi-hui;LIN Shao-mang;YAO Yan-dan;XIAO Jian-bin;HU Yi-ze
ZHANG Zhi-hui;LIN Shao-mang;YAO Yan-dan;XIAO Jian-bin;HU Yi-ze
..............page:65-68
Serial Changes in Circulating Platelet Activation and Platelet Aggregation After Carotid Artery Stenting
LIU Fang;WANG Da-ming;LIU Jia-chun;LI Jin;XU Xiao-dong;HAO Hong-jun;HUANG Yi-ning
LIU Fang;WANG Da-ming;LIU Jia-chun;LI Jin;XU Xiao-dong;HAO Hong-jun;HUANG Yi-ning
..............page:60-64,68
The Expression and Functions of Tissue Factor (TF) and Protease-Activated Receptors (PARs) on Tumor Cells
ZHOU Hong;HU Hong-xin;SHI Wen-xia;WANG Ting
ZHOU Hong;HU Hong-xin;SHI Wen-xia;WANG Ting
..............page:53-59
Antiplatelet Drug Resistance
BAO Cheng-xin
BAO Cheng-xin
..............page:51-52